SecSonar.com

ABVC BioPharma, Inc. (ABVC)

ABVC BioPharma, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

ABVC BioPharma, Inc. (ABVC) is a Biotechnology company based in US with a market capitalization of $20.3M. Free cash flow was negative at -$3M. This page tracks ABVC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 16 employees · IPO Nov 10, 2004

Valuation

Valuation & price

$1.14 · as of May 23, 2026 · -75.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.83

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.68$2.83$0.97Jul 25Dec 25Jul 26Jul 7, 25$3.99Jul 9, 25$4.68Jul 11, 25$3.97Jul 15, 25$3.57Jul 17, 25$3.58Jul 21, 25$3.52Jul 23, 25$3.07Jul 25, 25$3.01Jul 29, 25$2.98Jul 31, 25$2.40Aug 4, 25$3.20Aug 6, 25$2.86Aug 11, 25$2.95Aug 13, 25$2.97Aug 15, 25$3.30Aug 19, 25$2.85Aug 21, 25$3.04Aug 25, 25$2.93Aug 27, 25$2.98Aug 29, 25$2.83Sep 3, 25$2.71Sep 5, 25$2.65Sep 9, 25$2.75Sep 11, 25$2.77Sep 16, 25$2.84Sep 18, 25$2.72Sep 22, 25$2.87Sep 24, 25$3.23Sep 26, 25$3.16Sep 30, 25$3.04Oct 2, 25$3.02Oct 6, 25$3.13Oct 8, 25$3.24Oct 10, 25$3.04Oct 14, 25$2.98Oct 16, 25$2.92Oct 21, 25$2.92Oct 23, 25$2.92Oct 27, 25$2.89Oct 29, 25$2.77Oct 31, 25$2.80Nov 4, 25$2.82Nov 6, 25$2.84Nov 10, 25$2.85Nov 12, 25$2.99Nov 14, 25$2.92Nov 18, 25$2.92Nov 20, 25$2.66Nov 25, 25$2.57Nov 28, 25$2.71Dec 2, 25$2.55Dec 4, 25$2.53Dec 8, 25$2.12Dec 10, 25$2.23Dec 12, 25$2.11Dec 16, 25$2.06Dec 18, 25$2.04Dec 22, 25$2.35Dec 24, 25$2.33Dec 29, 25$2.31Jan 2, 26$2.19Jan 6, 26$2.27Jan 8, 26$2.25Jan 12, 26$2.08Jan 14, 26$2.08Jan 16, 26$2.02Jan 21, 26$2.05Jan 23, 26$2.06Jan 27, 26$2.06Jan 29, 26$2.08Feb 2, 26$1.89Feb 4, 26$1.90Feb 9, 26$1.73Feb 11, 26$1.73Feb 13, 26$1.67Feb 18, 26$1.60Feb 20, 26$1.51Feb 24, 26$1.40Feb 26, 26$1.29Mar 2, 26$1.48Mar 4, 26$1.45Mar 6, 26$1.34Mar 10, 26$1.46Mar 12, 26$1.37Mar 17, 26$1.33Mar 19, 26$1.29Mar 23, 26$1.23Mar 25, 26$1.08Mar 27, 26$1.00Mar 31, 26$0.97Apr 2, 26$1.09Apr 7, 26$1.45Apr 9, 26$1.43Apr 13, 26$1.38Apr 15, 26$1.31Apr 17, 26$1.32Apr 22, 26$1.18Apr 24, 26$1.07Apr 28, 26$1.07Apr 30, 26$1.03May 4, 26$1.05May 6, 26$1.10May 8, 26$1.06May 12, 26$1.05May 14, 26$1.08May 18, 26$1.07May 20, 26$1.10May 22, 26$1.14May 28, 26$1.41Jun 1, 26$1.36Jun 3, 26$1.28Jun 5, 26$1.33Jun 9, 26$1.32Jun 11, 26$1.31Jun 15, 26$1.26Jun 17, 26$1.36Jun 22, 26$1.32Jun 24, 26$1.33Jun 26, 26$1.53Jul 2, 26$1.80
$0.9152-week range$4.74
Loading valuation history…

Fundamentals

Key fundamentals

$20.3M

Market cap

—

Revenue growth (YoY)

99.8%

Gross margin

-$3M

Free cash flow (USD)

$2.7M

Net debt

99.2%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$7.0KFY 2019$701.7KFY 2020$483.0KFY 2021$355.8KFY 2022$969.8KFY 2023$152.4KFY 2024$509.6KFY 2025$0.00
$0$0

Free cash flow by year

2016 → 2025

FY 2016$-3.5MFY 2017$-1.7MFY 2018$-630.2KFY 2019$-3.1MFY 2020$-4.6MFY 2021$-7.6MFY 2022$-7.5MFY 2023$-4.2MFY 2024$-1.8MFY 2025$-3.0M
-$3.5M-$3M

Gross margin by year

2021 → 2024

FY 202198.6%FY 202270.5%FY 2023-98.2%FY 202499.8%
98.6%99.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 18, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAuditor ChangeJul 2, 2026Filing
  • Quarterly report10-Q FiledMay 18, 2026Filing

Questions

Frequently asked questions

What is ABVC BioPharma, Inc.'s market cap?

ABVC BioPharma, Inc. (ABVC) has a market capitalization of $20.3M.

What is ABVC's P/E ratio?

A meaningful P/E ratio is not available for ABVC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ABVC's price-to-book (P/B) ratio?

ABVC trades at 1.83 times book value per share.

Are insiders buying ABVC stock?

SEC Form 4 filings show no open-market insider buys at ABVC BioPharma, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

XCUR

Exicure, Inc.

$20.1M

SER

Serina Therapeutics, Inc.

$20M

PLUR

Pluri Inc.

$20.7M

KZIA

Kazia Therapeutics Limited

$20.8M

VTGN

VistaGen Therapeutics, Inc.

$20.9M

DARE

Daré Bioscience, Inc.

$21.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.